Should You Tell People You Take Ozempic or Zepbound? What to Say at Work, at Home and With Friends

You don’t have to tell anyone you take semaglutide (Ozempic, Wegovy) or tirzepatide (Zepbound, Mounjaro). It’s health information, and you decide who gets it. The exception is the healthcare professionals who treat you: they always need to know. For everyone else, it helps to ask what you gain by telling each person and to have two or three lines ready. You’ll find them here, along with what US workplace law says.

Why the question stings: weight stigma

It’s not just you. In 2020, 36 experts from several countries signed a joint international consensus statement for ending stigma of obesity, published in Nature Medicine and endorsed by more than 100 organizations. It concludes that^[1]:

• Body weight isn’t entirely under voluntary control. Assuming it is conflicts with a definitive body of biological and clinical evidence.
• Stigma causes harm: more depressive symptoms, anxiety, isolation and stress, and less seeking of medical care.
• Workplace weight discrimination is common in high-income countries.
• Surgery isn’t “the easy way out,” even though it’s often called that.

GLP-1s are getting the same treatment. In a study by Post and Persky (2024), 357 US adults read about a woman, either lean or with obesity, who lost 15% of her weight. When she did it with a GLP-1, they judged her more harshly than when she used diet and exercise, largely because they believed she’d taken a shortcut^[2]. In four experiments by Tissot and Roth (2026), 1,205 people in Belgium, the US and the UK compared two men who lost 20 kg (44 lb) with the same diet and exercise; one also took medication. He was rated less moral, warm, competent and deserving of his results, apparently because people assumed he’d made less effort^[3].

These were made-up stories rated in online surveys, not real-life observations. But they explain why “So how did you do it?” can feel like a test.

Obesity is a chronic disease, and treating it is ordinary medicine

The WHO classifies obesity as “a chronic, relapsing disease” arising from complex interactions between genetics, neurobiology, eating behaviors, access to a healthy diet, market forces and the broader environment^[4]. The American Medical Association recognizes obesity as a disease that requires a range of interventions^[6].

In December 2025, the WHO’s first guideline on GLP-1 medicines said they may be used by adults, except during pregnancy, for the long-term treatment of obesity, as part of comprehensive care with diet, physical activity and professional support. The recommendation is conditional, given limited long-term data, cost and equity concerns^[5].

And these drugs aren’t always prescribed for weight: tirzepatide, for example, is also sold as Mounjaro for type 2 diabetes^[12]. Whoever is asking doesn’t know why you were prescribed it, and doesn’t need to.

Do you have to tell your employer?

Generally, no. This is general information, not legal advice: if you’re facing a specific problem, talk to an employment lawyer or contact the EEOC.

• The ADA covers larger employers. Title I of the Americans with Disabilities Act applies to employers with 15 or more employees^[14].
• Medical questions have to be job-related. The EEOC’s guidance says disability-related inquiries of employees must be “job-related and consistent with business necessity.” These limits apply to all employees, not just those with a disability^[13].
• Asking everyone about their prescriptions is generally off-limits. The same guidance says asking all employees what prescription medications they take is generally not allowed. Some public-safety jobs are an exception^[13].
• What you share stays confidential. Medical information you volunteer must be treated as a confidential medical record, shared only in limited circumstances^[13].

State law may add its own rules; your state’s civil rights or labor agency can tell you what applies where you work.

If a side effect affects your work, such as nausea during a long shift, you can ask for an adjustment without naming the drug: “I’m on a medical treatment and for the next few weeks I need short breaks to eat.” If you make a formal accommodation request, the EEOC guidance lets your employer ask for documentation when the need isn’t obvious^[13].

What to say: scripts for common situations

Answer the question you were asked, not the one you fear they’re thinking. You don’t have to give everyone the same answer.

If you do tell someone, you can set limits up front: “I’m telling you, but I’d rather you didn’t pass it on.”

“That’s cheating” or “it’s the easy way out”

This one hurts the most, and there’s a factual answer.

People on GLP-1s still put in effort. In the trials, the drug was added to diet and activity counseling, not used instead of it^[7,8]. A 2025 joint advisory from four US medical and nutrition societies is an entire document on how to eat on these medicines^[9].

Stopping tends to bring the weight back. In STEP 4 (summary), people switched from semaglutide to placebo gained 6.9% over 48 weeks, while those who stayed on it lost another 7.9%^[7]. In SURMOUNT-4 (summary), people switched from tirzepatide to placebo gained 14.0% over 52 weeks, while those who continued lost another 5.5%^[8]. In both trials, everyone kept getting diet and exercise counseling^[7,8]. More in what happens when you stop Ozempic, Wegovy or Zepbound.

That isn’t a lack of willpower; it fits what the WHO calls a chronic, relapsing disease^[4]. And nobody calls a blood pressure pill cheating.

Lines you can use:

• “It’s a treatment for a chronic disease. It isn’t easier, it’s different.”
• “I still watch what I eat and I stay active. The medication helps with hunger.”
• “I’d rather not debate my health.”

You don’t need to convince anyone. These are for you, so you don’t freeze.

At the table: when people notice how little you eat

Eating less is the expected effect of the drug, and it shows at family meals. Replies that don’t start a debate:

• “I’m full, thanks. It was delicious.”
• “Could I take a little home?”
• “Big portions don’t sit well with me right now. I’ll have more later.”

Serving yourself, eating the protein first and taking leftovers home tend to be easier than arguing. More in eating out on Ozempic, Wegovy or Zepbound. For long days away from home, see filling snacks on GLP-1s.

When people say you’re too thin (or nobody says anything)

If people say you’re too thin, separate the comment from the facts. They may just be surprised by the change. What counts is what your doctor sees at follow-up, with your history and lab results. BMI alone says little, as I explain in what BMI measures. If the comments are about your face, see Ozempic face.

You can say: “Thanks for caring. My doctor is following me and my checkups are fine,” or “I’d rather we didn’t talk about my body.”

If nobody says anything, it doesn’t mean nobody noticed: many people avoid commenting on someone else’s weight, sometimes out of respect. If you want support, ask for it: “I’ve made a big change and I’d like to be able to talk about it with you.”

Your partner and your treatment

GLP-1s change couple plans: dinners out, splitting dessert, drinks on Friday. Your partner may feel left out or insecure, even if they don’t say it that way.

• Explain the mechanism, not just the result. “I feel full sooner and I’m less hungry. It’s not that I don’t want to have dinner with you.”
• Plan things that aren’t about food: a walk, a movie, cooking together.
• Talk early about insecurity if you sense it, including about how your body is changing.

If your partner pressures you to eat more than feels right, pushes you to stop treatment or mocks you, that isn’t about the medication. You deserve respect either way, and whether to continue or stop is a decision for you and your doctor.

Friends who ask for a “hookup” or a recommendation

The most useful thing you can do is recommend nothing and point them to their own doctor.

• Don’t share your medication. The Medication Guides for Wegovy and Zepbound both say not to give the medicine to other people, even if they have the same condition, because it may harm them. They also say not to share your pen or needles with other people, even if the needle has been changed, because you may give or get a serious infection^[10,11].Dotted underline: a drug-label fact; hover over it to see the date it was checked.
• Don’t offer your dose as a reference. Each person’s doctor sets it.
• Don’t pass along websites or sellers. In 2024, the WHO warned of rising reports of falsified semaglutide in all regions since 2022. Some lack the active ingredient; others contain an undeclared one, such as insulin^[15].

One option: “My doctor prescribed it after checking me out. Ask yours. Something else might suit you better.”

When a comment points to a real problem

Sometimes the person commenting sees something you don’t. Talk to your doctor if you notice any of these:

• You skip meals on purpose to lose more, you’re intensely afraid of regaining, or you see yourself as overweight when others say otherwise. According to MedlinePlus, severe food restriction, intense fear of gaining weight and a distorted body image are symptoms of anorexia nervosa^[16].
• You eat in secret and feel guilty afterward, or you make yourself throw up. MedlinePlus lists these among the symptoms of eating disorders, serious mental health conditions that can be treated^[16].
• You notice signs you’re not getting enough. The 2025 advisory lists fatigue beyond expected levels, excessive hair loss, skin flakiness or itching, muscle weakness, poor wound healing and unusual bruising^[9].

The same advisory recommends screening for eating disorders before starting a GLP-1^[9]. If you have or have had one, tell whoever prescribes it. Getting help from a mental health professional is part of treatment too.

Who always needs to know

No choice here: healthcare professionals need to know to treat you safely.

• Your doctors and your pharmacist. Both Medication Guides say to tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements^[10,11]. It works the other way too: anyone prescribing something else needs to know you’re on a GLP-1.
• Before surgery or any procedure with sedation. Both labels warn that the medicine may increase the chance of food getting into your lungs during surgery or other procedures, and tell you to inform all your healthcare providers before the procedure^[10,11]. That includes your dentist if you’ll be sedated.
• If you’re pregnant, planning a pregnancy or on the pill. Both Medication Guides say to tell your provider if you are pregnant or plan to become pregnant, because the medicine may harm your unborn baby^[10,11]. The Zepbound guide adds that birth control pills by mouth may not work as well, and your provider may recommend another method for 4 weeks after starting and after each dose increase^[11]. Tell whoever manages your contraception.

To remember everything at your appointment, use the doctor-visit checklist.

Frequently asked questions

Do I have to tell my boss I’m on Ozempic?

Generally, no. Under the ADA, employers generally can’t ask all employees about their prescriptions, and anything you share must be kept confidential^[13]. If a side effect affects your work, you can ask for an adjustment without naming the drug.

Is it cheating to lose weight with Zepbound?

No. The WHO and the AMA treat obesity as a disease^[4,6], and tirzepatide is a prescription treatment that’s added to diet and exercise, not used instead of them.

What do I say when people ask how I lost so much weight?

Whatever you want to share. “I’m working on my health with my doctor” is true and doesn’t commit you to details.

My family says I’m getting too thin. What should I do?

Thank them and bring it up with your doctor, including if you skip meals to lose more or you’re afraid of regaining.

A friend wants me to share my Ozempic or tell them where to get it. What do I say?

Tell them to talk to their doctor. The Medication Guides say the medicine shouldn’t be given to other people, even with the same condition, because it may harm them^[10,11].